Lyell Immunopharma
LYEL
$2.25
Share price
3.69%
Change (1 day)
5.14%
Change (1 year)
Categories
Operating Margin for Lyell Immunopharma (LYEL)
Operating Margin as of April 2024 (TTM): -664.64%
According to Lyell Immunopharma's latest financial reports and stock price the company's current Operating Margin is -664.64%. At the end of 2021 the company had an Operating Margin of -2,349.47%.
Operating Margin history for Lyell Immunopharma from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -2,349.47% | -10.88% |
| 2020 | -2,636.31% | -86.61% |
| 2019 | -19,692.09% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.